[APDN] Applied DNA Sciences Inc


Type of security: Stock

Sector: Consumer Services

Industry: Other Consumer Services

Market Capitalization: 77.3 M

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 2 Change: -0.05 (-2.44%)
Ext. hours: Change: 0 (0%)

chart APDN

Refresh chart

Strongest Trends Summary For APDN

APDN is in the long-term down -91% below S&P in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Applied DNA Sciences, Inc. provides botanical-DNA based anti-counterfeiting and product authentication solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe, and Asia. The company offers SigNature DNA markers for embedment into a range of media, such as inks, dyes, textile treatments, thermal ribbon thread, laminates, glues, threads, varnishes, adhesives, and metal coatings; SigNature T botanical DNA markers for use in brand protection efforts and raw material source compliance programs; and SmartDNA, a patented security system for stores, warehouses, banks, pharmacies, and ATMs, as well as for the protection of valuables. It also provides DNANet tactical DNA products for law enforcement in the form of DNA-marked fixative sprays and liquids; digitalDNA, a DNA-secured form of the quick read code to create customer interface; fiberTyping solution, which is used in DNA verification for manufacturers, retailers, and brand owners to ensure quality, saf

Fundamental Ratios
Shares Outstanding24.08 M EPS-0.53 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 80.62% Sales Growth - Q/Q22.3% P/E-1.89
P/E To EPS Growth P/S18.2 P/BV39.54 Price/Cash Per Share
Price/Free Cash Flow-8.84 ROA-378.83% ROE-702.45% ROI
Current Ratio1.38 Quick Ratio Long Term Debt/Equity Debt Ratio0.85
Gross Margin Operating Margin-259.56% Net Profit Margin-323.45% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities3.8 M Cash From Investing Activities-230 K Cash From Operating Activities-3.97 M Gross Profit
Net Profit-1.89 M Operating Profit-1.88 M Total Assets3.63 M Total Current Assets2.3 M
Total Current Liabilities1.67 M Total Debt Total Liabilities1.67 M Total Revenue1.52 M
Technical Data
High 52 week2.68 Low 52 week1.11 Last close1.12 Last change-4.27%
RSI16.67 Average true range0.09 Beta0.35 Volume207.81 K
Simple moving average 20 days-17.19% Simple moving average 50 days-13.63% Simple moving average 200 days-20.54%
Performance Data
Performance Week-9.68% Performance Month-24.83% Performance Quart-18.84% Performance Half-25.33%
Performance Year-54.47% Performance Year-to-date-29.56% Volatility daily3.32% Volatility weekly7.43%
Volatility monthly15.24% Volatility yearly52.78% Relative Volume261.52% Average Volume146.41 K
New High New Low


2019-11-15 12:12:27 | Rediscovering The Virtue Of Small Size

2019-11-15 12:08:00 | Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering

2019-11-13 10:27:00 | Applied DNA's stock plunges as stock and warrant offering comes a day after a 4-fold rally

2019-11-13 09:20:00 | Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering

2019-11-13 08:36:48 | Benzinga Pro's Top 5 Stocks To Watch For Wed., Nov. 13, 2019: CSCO, NVTR, TWOU, APDN, GOOS

2019-11-13 07:55:00 | The Dow Is Down as Hong Kong Protests Continue. Fed Testimony Is the Key Today.

2019-11-12 17:13:44 | Applied DNA Stock Surges On DNA Leather Tagging News; Offering Expected Wednesday

2019-11-12 09:03:00 | Successful DNA Tagging of Leather at One of the World’s Largest Tanneries

2019-11-08 15:22:00 | Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors 

2019-10-31 13:00:00 | Applied DNA Sciences Announces 1-For-40 Reverse Stock Split

2019-10-22 08:30:00 | Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials

2019-10-16 05:30:00 | Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance

2019-10-04 05:00:00 | Molecular Tagging of Pharmaceutical Excipients Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal

2019-10-03 05:00:00 | Applied DNA Receives Extension from Nasdaq

2019-10-01 08:30:00 | LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Prostate Cancer Trial

2019-09-24 09:00:00 | Applied DNA Receives $1 Million Order to Supply SigNature® T Molecular Taggant for 2019-2020 Cotton Harvest Season

2019-09-19 04:00:00 | LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction

2019-09-05 05:30:00 | Applied DNA Extends Textiles Business to Include Global Down and Feather Supply Chain in Partnership with Industry Leader Navarpluma

2019-08-17 14:18:44 | Edited Transcript of APDN earnings conference call or presentation 13-Aug-19 8:30pm GMT

2019-08-13 16:05:00 | Applied DNA Reports Fiscal Third Quarter 2019 Financial Results

2019-08-12 09:00:00 | Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx

2019-08-08 05:30:00 | LineaRx Acquires Assets and Intellectual Property of Vitatex

2019-08-07 08:30:00 | Applied DNA Signs Master Services Agreement with Schreiner Group to Deliver SigNature® DNA Labels to Protect Pharmaceutical Supply Chains

2019-08-06 05:00:00 | Applied DNA Schedules Fiscal 2019 Third Quarter Financial Results Conference Call for Tuesday, August 13, 2019 at 4:30 PM ET

2019-08-05 09:00:00 | Applied DNA and TheraCann International Sign Term Sheet to Amend Licensing and Cooperation Agreement

2019-07-17 13:50:06 | How Much Of Applied DNA Sciences, Inc. NASDAQ:APDN Do Insiders Own?

2019-07-17 11:07:00 | Applied DNA Raises $1.5 Million In Secured Convertible Notes

2019-07-02 09:25:00 | Applied DNA Signs 5-Year Agreement with Iconic Writing Instrument Specialist Montblanc-Simplo GMBH to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients

2019-07-01 12:38:24 | Edited Transcript of APDN earnings conference call or presentation 9-May-19 8:30pm GMT

2019-07-01 09:25:00 | LineaRx Receives Multiple Purchase Orders for Linear DNA for Use in Therapeutic Development

2019-06-26 09:15:00 | LineaRx Ships DNA to Support Therapy Development for Neurodegenerative Diseases

2019-06-24 08:05:00 | TheraCann Adds Blockchain Functionality to ETCH biotrace Platform Powered by Applied DNA 

2019-06-14 08:00:00 | Molecular Tagging of Pharmaceutical Drugs Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal

2019-06-10 08:00:00 | Applied DNA Cannabis Partner TheraCann International Secures Agreement with South Africa’s House of Hemp

2019-06-04 08:00:00 | Applied DNA and Integrated Supply Chain Partners Scale Up to Provide Global Material Traceability for Companies Declaring “2020” Sustainability Goals

2019-05-30 08:00:00 | Applied DNA Closes the Loop on Traceability for Egyptian Pima with Genotyping Assays for Cotton Authentication

2019-05-21 05:30:00 | LineaRx Anticipates Expansion in Diagnostics Market via Follow-on Order and New Linear DNA Amplicons for Additional Assay

2019-05-15 08:04:00 | TheraCann and CannAcubed Enter Collaboration Agreement to Validate Cannabis and Hemp Supply Chain in China

2019-05-10 05:00:00 | Applied DNA to Webcast 2019 Annual Stockholders’ Meeting

2019-05-09 17:40:41 | Applied DNA Sciences: Fiscal 2Q Earnings Snapshot

2019-05-09 16:05:00 | Applied DNA Reports Fiscal Second Quarter 2019 Financial Results

2019-05-08 08:30:00 | A&E to Preview ‘Integrity’ Molecular-Tagged Thread Solution From Applied DNA Sciences at Texprocess

2019-05-02 05:30:00 | Applied DNA’s Molecular Tagging Technology to Ensure Authenticity of Egyptian Cotton

2019-05-02 04:00:00 | Applied DNA Schedules Fiscal 2019 Second Quarter Financial Results Conference Call for Thursday, May 9, 2019 at 4:30 PM ET

2019-04-29 11:44:48 | If You Had Bought Applied DNA Sciences NASDAQ:APDN Stock Five Years Ago, You'd Be Sitting On A 92% Loss, Today

2019-04-29 09:15:00 | LineaRx Achieves Higher Expression and Survival Rates in Human T Cells Transfected Non-Virally with Linear DNA

2019-04-24 13:00:00 | Applied DNA Receives Initial $1 Million Payment from TheraCann International

2019-04-22 14:09:00 | Applied DNA and GHCL Launch “REKOOP” Verified by the CertainT Platform on Amazon.com on Earth Day

2019-04-12 03:00:00 | Applied DNA Signs Memorandum of Understanding with Process Chemicals Leader Stahl to Bring CertainT® Platform to Manufacturing Supply Chains

2019-04-08 08:00:00 | Applied DNA Subsidiary LineaRx Achieves Biotech Industry First with Anti-CD19 Expression in Human CAR T Cells via Proprietary Non-Viral, Plasmid-Free Platform